CYTK - Cytokinetics Inc
IEX Last Trade
57.06
-0.330 -0.578%
Share volume: 1,080,796
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$57.39
-0.33
-0.58%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-06 | 2022-08-05 | 2022-11-04 | 2023-03-01 | 2023-05-05 | 2023-08-03 | 2023-11-03 | 2024-02-28 | |
| Assets | |||||||||
| Total Assets | 856.253 M | 771.717 M | 1.076 B | 1.015 B | 889.815 M | 779.899 M | 740.614 M | 824.316 M | |
| Current Assets | 623.526 M | 602.250 M | 884.275 M | 795.186 M | 680.629 M | 586.575 M | 561.416 M | 628.051 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 8.496 M | 14.251 M | 14.317 M | 12.462 M | 15.661 M | 19.868 M | 19.678 M | 11.944 M | |
| Short Term Investments | 8.496 M | 14.251 M | 14.317 M | 12.462 M | 15.661 M | 19.868 M | 19.678 M | 11.944 M | |
| Total Receivables | 6.056 M | 1.973 M | 2.294 M | 147.000 K | 1.006 M | 985.000 K | 2.499 M | 1.283 M | |
| Current Cash | 608.974 M | 586.026 M | 867.664 M | 782.577 M | 663.962 M | 565.722 M | 539.239 M | 614.824 M | |
| Total Non-current Assets | 232.727 M | 169.467 M | 191.686 M | 219.589 M | 209.186 M | 193.324 M | 179.198 M | 196.265 M | |
| Property Plant Equipment | 75.740 M | 78.586 M | 80.302 M | 80.453 M | 78.859 M | 77.248 M | 75.614 M | 68.748 M | |
| Other Assets | 7.258 M | 8.052 M | 7.764 M | 9.691 M | 8.119 M | 8.339 M | 8.187 M | 7.996 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 856.253 M | 771.717 M | 1.076 B | 1.015 B | 889.815 M | 779.899 M | 740.614 M | 824.316 M | |
| Total liabilities | 739.992 M | 660.303 M | 1.092 B | 1.123 B | 1.119 B | 1.113 B | 1.179 B | 1.211 B | |
| Total current liabilities | 66.847 M | 66.843 M | 76.496 M | 84.617 M | 75.220 M | 65.617 M | 77.723 M | 102.678 M | |
| Accounts Payable | 19.836 M | 14.078 M | 14.429 M | 25.611 M | 17.357 M | 12.561 M | 13.796 M | 21.507 M | |
| Other liabilities | 365.446 M | 283.710 M | 292.507 M | 301.545 M | 307.651 M | 313.788 M | 370.457 M | 380.161 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 10.080 M | |
| Long term debt | 195.676 M | 197.018 M | 608.530 M | 609.618 M | 610.623 M | 609.780 M | 609.019 M | 607.373 M | |
| Other liabilities | 365.446 M | 283.710 M | 292.507 M | 301.545 M | 307.651 M | 313.788 M | 370.457 M | 380.161 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 116.261 M | 111.414 M | -15.977 M | -107.900 M | -229.020 M | -333.115 M | -438.801 M | -386.323 M | |
| Common stock | 84.996 M | 85.731 M | 93.758 M | 94.815 M | 95.164 M | 95.755 M | 96.071 M | 99.106 M | |
| Retained earnings | -1.286 B | -1.306 B | -1.449 B | -1.586 B | -1.717 B | -1.846 B | -1.975 B | -2.112 B |